Cargando…
Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease
[Image: see text] Blood-circulating biomarkers have the potential to detect Alzheimer’s disease (AD) pathology before clinical symptoms emerge and to improve the outcomes of clinical trials for disease-modifying therapies. Despite recent advances in understanding concomitant systemic abnormalities,...
Autores principales: | Hadjidemetriou, Marilena, Rivers-Auty, Jack, Papafilippou, Lana, Eales, James, Kellett, Katherine A. B., Hooper, Nigel M., Lawrence, Catherine B., Kostarelos, Kostas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155389/ https://www.ncbi.nlm.nih.gov/pubmed/33730479 http://dx.doi.org/10.1021/acsnano.1c00658 |
Ejemplares similares
-
Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
por: Rivers-Auty, Jack, et al.
Publicado: (2020) -
Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease
por: Martins, Isaura V.A., et al.
Publicado: (2016) -
Dynamic interactions and intracellular fate of label-free, thin graphene oxide sheets within mammalian cells: role of lateral sheet size
por: Chen, Yingxian, et al.
Publicado: (2021) -
Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
por: Rowland, Helen A., et al.
Publicado: (2018) -
Tagging and Enriching Proteins Enables Cell-Specific Proteomics
por: Elliott, Thomas S., et al.
Publicado: (2016)